Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - LONG-TERM INVESTMENTS
Long-term Investments REGN - Regeneron Pharmaceuticals, Inc.
5.4 B
LAST VALUE
-11.16%
2 YEAR CAGR
25.19%
5 YEAR CAGR
30.05%
10 YEAR CAGR